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Original Article
Abstract
Background and aims: Klebsiella is an opportunistic organism that is the cause of severe diseases such as pneumonia, septicemia, and 
urinary tract infections (UTIs). In addition, high antibiotic resistance has challenged the treatment of this bacterium. However, carbapenem 
antibiotics are considered as the therapeutic agents for selecting the treatment of penicillin- and cephalosporin-resistant gram-negative 
bacterial infections. The present study aimed to determine the resistance and minimum inhibitory concentration (MIC) of meropenem and 
imipenem.
Methods: A total of 80 Klebsiella spp isolated from UTIs were collected in various educational wards (i.e., urology, obstetrics, and 
gynecology, as well as the units of infectious diseases, internal medicine, and intensive care) in different hospitals of Shahrekord. The 
isolates were then identified by using biochemical tests. Further, disc diffusion method was employed to determine the antibiotic resistance. 
Furthermore, MIC was estimated by the Epsilon-test strip. Moreover, P=Q=0.50, an error of 0.05, and an accuracy of 0.11 were considered 
for determining the sample size (n = 80).
Results: Based on the results of disc diffusion method, 24 strains were resistant to meropenem and imipenem. Additionally, the MIC was 24 
(30%) by the E-test. In addition, 24 isolates had a MIC of ≥4 μg/mL for meropenem and imipenem and thus were resistant while 18 isolates 
were found to have a MIC of 1≤ MIC<4 μg/mL and therefore, were considered semi-sensitive (P < 0.001).
Conclusion: In general, Klebsiella strains were found to be resistant to meropenem and imipenem. Therefore, rapid and accurate 
identification of these strains and the selection of appropriate antibiotics can help quickly eradicate the infections caused by these bacteria. 
Accordingly, a waste of time, the consumption of medication, or even an increased resistance are prevented.
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Introduction 
Urinary tract infection (UTI) is the second leading 
reported infection in patients since nearly seven million 
patients are annually treated by the doctors (1). The 
presence of over 105 colony forming units (CFU)/mL 
of a bacterium in the urine sample indicates the UTI. 
Klebsiella strains are one of the major bacterial causes 
of the UTI (2). Klebsiella is an opportunistic bacterium 
which is related to severe conditions such as pneumonia, 
septicemia, and UTIs. The importance of this bacterium, 
as a human pathogen, is associated with the development 
of hospital infections in patients with immunodeficiency 
and underlying diseases such as diabetes mellitus and 
chronic pulmonary problems (3). UTIs are the most 
common infections among Klebsiella infections. The risk 
of UTI acquisition is far higher than the normal rate in 
people with bladder infections and diabetes (4). In recent 
years, the emergence of Klebsiella strains with multidrug 
resistance (MDR) has been observed due to the over-
the-counter and excessive consumption of the antibiotics 
(5). In addition, antimicrobial resistance is always a 
major concern for human health and affects patients in 
hospitals across the world (6,7). Further, carbapenem 
antibiotics include ertapenem, imipenem, doripenem, 
and meropenem. The carbapenemase enzymes belong 
to the molecular classes A, B, and D, which are able to 
inactivate carbapenem antibiotics such as meropenem 
and imipenem.  Among the carbapenemase enzymes, 
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Klebsiella pneumoniae carbapenemase, which is a class 
A carbapenemase, is inhibited by different degrees of 
clavulanate and hydrolyzes penicillins and cephalosporins 
more than carbapenems. This enzyme is considered an 
extended broad-spectrum β-lactamase (ESBL) since it 
lacks a robust carbapenemase activity. Furthermore, 
class B carbapenemases (Bush group 3) are known as 
the metallo-beta-lactamases that hydrolyze carbapenem 
antibiotics except for the aztreonam and are resistant 
to β-lactamase enzyme inhibitors such as clavulanate. 
However, these lactamases are inhibited by the chelating 
agents such as ethylenediaminetetraacetic acid which can 
degrade and inhibit carbapnemase enzymes, and therefore, 
it is a component of the diagnostic tests for these enzymes 
(8, 9). Carbapenem antibiotics are the drugs of the choice 
for treating the infections caused by gram-negative bacilli 
resistant to penicillin and cephalosporins due to being a 
broad spectrum and lacking the hydrolysis by beta-lactams 
(10,11). Moreover, these antibiotics are currently regarded 
as the drugs of choice for treating serious infections 
related to MDR and ESBL-producing Enterobacteriaceae 
(12,13). Infections caused by the MDR gram-negative 
bacteria lead to higher morbidity and mortality, long-
term hospital stay, increased health care costs, and limited 
therapeutic options (14,15). Therefore, these resistant 
bacteria should be identified using different methods 
such as antibiotic susceptibility testing, the determination 
of minimum inhibitory concentration (MIC), and 
genotype confirmatory tests including a polymerase chain 
reaction. Epsilon-test (E-test) is the most accurate method 
for determining the MIC of the antibiotics (16). If the 
bacterium is resistant to carbapenems, treatment with 
carbapenem alone cannot lead to patient recovery while 
it leads to the emergence of antibiotic-resistant bacteria, 
prolong medical treatments, or even mortality in the 
patients. Accordingly, the current study sought to detect 
meropenem- and imipenem-resistant Klebsiella strains 
by disc diffusion method in patients with UTI and to 
evaluate the resistance by MIC of these strains using the 
E-test strip.
Materials and Methods
In this descriptive-analytical study, 80 Klebsiella isolates 
(i.e., 74 pneumonia and 6 oxytoca isolates) were collected 
from patients with UTI in different wards (e.g., urology, 
obstetrics, and gynecology, in addition to infectious 
diseases, internal medicine, and intensive care units) of 
Hajar (48 isolates) and Kashani (32 isolates) Educational 
Hospitals during (21 April-22 October) 2016-2017. 
Additionally, using the statistical formula, the sample size 
was determined 80 by taking into account the maximum 
prevalence of P=Q=0.50, the error of 0.05, and an 
accuracy of 0.11. The inclusion criterion was Klebsiella 
isolates separated from patients with UTI 48-72 hours 
after hospitalization, and their primary urinary culture was 
negative at the time of referring to the hospital. In addition, 
the exclusion criterion encompassed a history of antibiotic 
usage. To isolate the samples, first, the information 
of the admitted patients including the hospitalization 
record and antibiotic usage within two weeks before the 
sampling, which was collected by using a questionnaire. 
The isolates were first cultured on blood Agar and eosin 
methylene blue (Himedia, India) and then the bacteria 
were identified employing biochemical differential tests 
such as the triple sugar iron, Simmons Citrate, methyl red, 
Voges–Proskauer, indole, mobility, oxidase, and catalase 
(Himedia, India). Following identifying and confirming 
the phenotypes of the Klebsiella bacterium (pneumonia 
and oxytoca), they were inoculated from the colony of 
the purified bacteria to 1.5 μM microtubes containing 
700 μL of the sterile tryptic soy broth (Himedia, India) 
and incubated overnight at 37°C. After the growth of the 
bacteria in the medium, 300 μL of sterilized glycerol (15% 
concentration) was added to medium and the bacteria 
were stored in a freezer at -70°C to prevent the death of 
the bacteria in a long time. Further, the criteria proposed 
by the Clinical and Laboratory Standard Institute were 
used (17) in order to identify the Klebsiella strains. For 
this purpose, first, a suspension of the pure culture of the 
bacteria, equivalent to 0.5 McFarland standard (1.5 × 
108 CFU/mL), was prepared and then cultivated on the 
Mueller-Hinton agar (Merck, Germany). Next, the culture 
media were incubated at 37°C for 18-24 hours. The 
antibiotic susceptibility of the bacteria was determined 
by disc diffusion method (Kirby-Bauer method) for two 
antibiotics, namely, meropenem and imipenem (10 μg 
each, MAST, England). After incubation, the diameter 
of the inhibition zone was measured and interpreted 
according to the standard antibiogram. Furthermore, the 
resistance of the strains to meropenem and imipenem 
was identified by determining the MIC using the E-test 
Liofilcheme (Italy) with a concentration range of 0.002-32 
μg/mL. Moreover, the bacterial suspension, equal to 0.5 
McFarland turbidity, was prepared from fresh and pure 
bacterial culture and cultivated on the Mueller-Hinton 
agar. Then, the strip was placed on the medium and 
incubated at 3 °C for 16-18 hours (18-21).
Results
The data related to the isolates from different wards of the 
hospital are presented in Tables 1 and 2. As shown, most 
samples were collected from the patients in the urology 
ward while the least samples were taken from the intensive 
care unit (ICU). A number of 34 (42.5%) and 46 (57.5%) 
out of 80 patients with UTI, within the five-month 
period of sampling, were males and females, respectively, 
showing a higher incidence of UTI in women. In addition, 
respecting the prevalence of antibiotic resistance in men 
and women, the number of meropenem- and imipenem-
resistant samples was higher in women (n = 16) compared 
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to men (n = 8), indicating a significantly higher prevalence 
of resistance to these antibiotics in women than men 
(Table 3). Additionally, as regards the age, the patients 
were within the age range of 4-72 years old. Further, most 
cases with UTI were 28-45 years old and the prevalence 
of antibiotic resistance was higher in older patients (34-45 
years) compared to the younger ones. A total of 30% (i.e., 
24 isolates including 22 pneumonia and 2 oxytoca isolates) 
were resistant to meropenem and imipenem based on the 
disc diffusion results (Tables 1 and 2). Furthermore, the 
E-test strips were read from the top to the bottom of the 
strip (i.e., high to low concentrations of the antibiotics) 
after 18 hours of incubation. The antibiotic penetration 
from the strip into the medium containing agar caused an 
oval zone. Moreover, the MIC was decided to be the point 
where the oval zone crossed the strip (21,22).
Based on the MICs, 24 (30%) isolates were resistant 
to meropenem and imipenem with a MIC of ≥4 μg/mL 
whereas 18 isolates had a MIC of 1≤ MIC<4  and were 
found to be semisensitive. Tables 4 and 5 separately 
present the MIC results for the Klebsiella species (i.e., 
pneumoniae and oxytoca). Only 2 out of the 6 oxytoca 
isolates were resistant to meropenem and imipenem, 
indicating the resistance among other Klebsiella species. 
Additionally, it demonstrates that this resistance is limited 
to no pneumonia.
Regarding the number of meropenem and imipenem-
resistant, the majority of the isolates were separated from 
the patients in the infectious disease wards. None of the 
strains were isolated from the internal ward and intensive 
care unit had a MIC of ≥4 μg/mL. Based on the results of the 
disc diffusion method and E-test, the number of resistant 
isolates was equal. These isolates were completely resistant 
to meropenem and imipenem, and their MICs were even 
greater than 8 μg/mL, which confirmed the high resistance 
of these samples by the diffusion method. However, the 
number of these strains (18 isolates) was higher in semi-
sensitive strains compared to the disc diffusion results 
(10 isolates), which was due to the higher accuracy and 
greater sensitivity of the E-test strip compared to the disc 
diffusion method regarding identifying semi-sensitive and 
resistant strains. The significance level for the results of the 
Fisher exact test was considered P < 0.001, and the results 
were found to be significant with respect to the number 
of strains isolated in each ward and the resistance level. 
Figures 1A and 1B illustrate the E-test bar for morphine 
and imipenem strains.
Discussion
The most common cause of UTI is Escherichia coli, followed 
by Klebsiella and Staphylococcus saprophyticus species (23). 
The importance of Klebsiella, as a human pathogenic 
agent, is related to the development of nosocomial 
infections and UTIs (24). The release of drug resistance 
factors in gram-negative bacteria and Klebsiella leads to 
an increase in the resistance of these microorganisms to 
various antibiotics. Therefore, therapeutic procedures for 
the patients are elongated (25,26). In the present study, 
24 isolates were meropenem and imipenem resistant 
with MIC ≥4 while 18 isolates were found to be semi-
sensitive with 1≤ MIC<4, which is in line with the results 
of Nobari et al in Iran, where in an investigation regarding 
resistance to carbapenems in 180 Klebsiella isolates, they 
observed that 42 isolates were resistant to meropenem 
whereas 29 and 14 isolated were resistant to ertapenem 
Table 1. The antibiotic results for meropenem and imipenem and the number 
of Klebsiella pneumoniae isolates in different wards
Wards
Klebsiella 
pneumonia (n)
Resistant 
(n)
Semisensitive 
(n)
Sensitive 
(n)
Urology 22 8 4 10
Obstetrics and 
gynecology
14 4 2 8
Infectious diseases 20 11 1 8
Internal medicine 10 0 0 10
Intensive care unit 8 0 2 6
Table 2. The antibiotic results for both meropenem and imipenem antibiotics 
and the number of Klebsiella oxytoca isolates in different wards
Wards
Klebsiella 
oxytoca (n)
Resistant 
(n)
Semisensitive 
(n)
Sensitive 
(n)
Urology 2 1 0 1
Obstetrics and 
gynecology
1 0 1 0
Infectious diseases 2 1 0 1
Internal medicine 1 0 0 1
Intensive care unit 0 0 0 0
Table 3. The antibiogram results of meropenem and imipenem in men and 
women
Totals samples Resistant
Men 34 8
Women 46 16
Table 4. The MIC of imipenem and meropenem antibiotics in Klebsiella 
pneumoniae isolates
Antibiotic
Resistant (n) 
MIC≥4
Semisensitive (n) 1≤ 
MIC<4
Sensitive (n) 
MIC<1
Meropenem 22 17 35
Imipenem 22 17 35
Table 5. The MIC of imipenem and meropenem antibiotics in Klebsiella 
oxytoca isolates
Antibiotic
Resistant (n) 
MIC≥4
Semisensitive (n) 1≤ 
MIC<4
Sensitive (n) 
MIC<1
Meropenem 2 1 3
Imipenem 2 1 3
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and imipenem, respectively. In terms of the number 
of meropenem-resistant isolates in the total number of 
isolates, their results are consistent with the findings of 
the current study. The low number of imipenem-resistant 
strains compared to meropenem and ertapenem resistant 
ones in the study by Nobari et al may be due to several 
reasons such as the rate of treatment with imipenem in 
the study setting, the antibiotic susceptibility pattern of 
the studied samples, being inpatient or outpatient, and the 
like (27). In addition, in another study by Kanchanadevi et 
al in India, 25 out of 76 E. coli isolates, 2 out of 9 Klebsiella 
isolates, and 42 out of 60 Pseudomonas isolates were found 
to be resistant to imipenem based on the MIC results by 
using E-test, which is approximately consistent with the 
results of the current study with respect to the number 
of imipenem-resistant Klebsiella isolates per the total 
number of the isolates, indicating a lower prevalence of 
carbapenem resistance in Klebsiella and E. coli compared to 
Pseudomonas (28). Further, based on the results of previous 
studies, antibiotic resistance in Iran has been risen due to 
the excessive and over the counter use of antibiotics, as well 
as the acquisition of antibiotic resistance factors such as 
resistance genes spread through various methods including 
conjugation in the Klebsiella strains. The existence of 
this resistance was observed in the current study, which 
confirms this argument (29,30). Furthermore, in a study 
by Tawfik et al, 87 inpatients in the ICU were investigated, 
46 of whom were colonized with different bacterial agents. 
All of these bacteria were examined for resistance to 
carbapenems, the results of which demonstrated that 20 
(43.5%) Pseudomonas aeruginosa, 11 (23.9%) Acinetobacter 
baumannii, 3 (6.5%) E. coli, 2 (4.3%) K. pneumoniae, and 
1 (2.2%) Enterobacter were resistant to carbapenems, 
which contradicts the results of the present study with 
Meropenem Imipenem
Figure 1. (A)The E-test strip of meropenem and imipenem-sensitive strain 
(MIC<1). (B) The E-test strip of meropenem and imipenem resistant strain. 
respect to resistant Klebsiella isolates from the patients in 
the ICU. In this study, a total of 8 isolates were obtained 
from the patients in the ICU, none of which were resistant 
to meropenem and imipenem (31). Based on the findings 
and statistics, the prevalence of antibiotic-, meropenem-, 
and imipenem-resistant strains varies in different parts of 
the world. The results of the present study represented that 
Klebsiella strains isolated from patients with UTIs who were 
admitted to the wards of the hospital were significantly 
resistant to meropenem and imipenem, which indicates 
the colonization rate of Klebsiella strains in the hospital 
environment and higher sensitivity of these patients to 
obtain these organisms. The extensive and over-the-
counter use of third-generation cephalosporins causes this 
resistance. If antibiotic resistance continues, antibiotics 
are likely to be effective in treating the infections resulted 
from these microorganisms. Moreover, the causes of low 
resistance to imipenem and meropenem compared to other 
antibiotics in various studies, as well as the current study, 
include low use of these antibiotics among the treatment 
teams and the lack of its use in outpatients since they are 
among the antibiotics used in hospitalized patients only 
with the physician’ prescription, and the lower incidence 
of carbapnemase enzymes in the Enterobacteriaceae 
family compared to other bacteria (32-35).  In a study 
conducted by Validi et al in Iran, of the 75 Klebsiella 
isolates obtained from the stool, blood, urine, phlegm, 
and wound, the least antibiotic resistance was observed 
with respect to meropenem and imipenem, and only one 
sample was resistant to these two antibiotics, which is not 
consistent with the results of the present study regarding 
the prevalence of resistance of these antibiotics. This can 
be due to the awareness of individuals in a region about 
the consequences of over-the-counter antibiotic use which 
makes the users predisposed to acquiring resistance, as well 
as the different prevalence of the genes responsible for this 
resistance in different regions (36). In this study, the most 
samples of UTI at the time of the specific sampling were 
from females, which indicates the higher incidence of the 
infection in women. This statistically corroborates with 
the findings of the other studies conducted in different 
parts of the world. The prevalence is more common in 
women compared to men, with almost half of the world’s 
women experiencing this infection at least once in their 
lifetime (37). The proximity of the genitalia to the 
urethra (38), pregnancy, and sexual activity are the causes 
of the high prevalence of UTI in women. Additionally, 
many cases of UTI are treated as gastrointestinal or 
even respiratory infections, which increases the risk of 
developing pyelonephritis, urinary stones, preterm labor, 
and fetal death (39). In terms of age, the incidence of UTI 
increases with increasing age in both genders.  However, 
the acquisition of this infection is lower in young men 
within the same duration, which matches the results of the 
current study where the number of UTI cases was lower 
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in the people with lower ages (40). In addition, regarding 
the prevalence of antibiotic resistance in men and women, 
in the present study, the resistance to meropenem and 
imipenem was higher in women compared to men and in 
the middle-aged and older women compared to younger 
ones. Further, Doosti et al in their study on 120 samples of 
UTI found a comparatively higher prevalence of antibiotic 
resistance in women than men and in people aged 27-
39 years and older compared to the younger ones (41). 
Furthermore, Mohammadi et al observed that resistance 
to antibiotics and beta-lactams was higher in women 
compared to men among the hospitalized patients (42), 
which is in line with the results of the current study with 
respect to the prevalence of resistance in women and men. 
Conclusion
In general, based on the findings of this study, Klebsiella 
is the cause of UTI and resistant to meropenem and 
imipenem, which is consistent with the findings of other 
similar studies. Accordingly, physicians’ awareness of 
resistance to antibiotics and bacteriological agents in every 
region is of great importance. Therefore, controlling the 
increase of this resistance is needed to prevent the over-
the-counter use of antibiotics. Furthermore, pharmacies 
should not be allowed to sell the antibiotics without a 
doctor’s prescription. As a result, future researchers are 
recommended to implement further studies on genes and 
enzymes that contribute to resistance to carbapenems and 
use faster diagnostic methods such as polymerase chain 
reaction in subsequent studies in order to prevent the 
increased therapeutic costs and the spread of this resistance.
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